Encompass Health Corp/ US29261A1007 /
04.06.2024 21:59:05 | Diff. +1,01 | Volumen | Geld22:25:01 | Brief22:25:01 | Marktkapitalisierung | Dividendenr. | KGV |
---|---|---|---|---|---|---|---|
84,57USD | +1,21% | 25.137 Umsatz: 883.147,51 |
-Geld Vol: - | -Brief Vol: - | 8,51 Mrd.USD | 0,71% | 24,07 |
Aktiva
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sachanlagen | 910,5000 | 1.019,7000 | 1.310,1000 | 1.391,8000 | 1.517,1000 | ||||||
Immaterielle Vermögensgegenstände | 88,2000 | 306,1000 | 419,4000 | 411,3000 | 403,1000 | ||||||
Finanzanlagen | 0.0000 | - | - | - | - | ||||||
Anlagevermögen | - | - | - | - | 4.191,5000 | ||||||
Vorräte | - | - | - | - | - | ||||||
Forderungen | 261,8000 | 323,2000 | 410,5000 | 443,8000 | 472,1000 | ||||||
Liquide Mitteln | 64,5000 | 66,7000 | 61,6000 | 40,5000 | 54,4000 | ||||||
Umlaufvermögen | 580,4000 | 686,6000 | 598,7000 | 654,5000 | 702,2000 | ||||||
Aktiva, gesamt | 2.534,4000 | 3.408,8000 | 4.606,1000 | 4.681,9000 | 4.893,7000 |
Passiva
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Verbindlichkeiten aus Lieferungen und Leistungen | 61,9000 | 53,4000 | 61,6000 | 68,3000 | 78,4000 | ||||||
Langfristige Schulden | 1.505,2000 | 2.110,8000 | 3.134,7000 | 2.979,3000 | 2.545,4000 | ||||||
Verbindlichkeiten gegenüber Kreditinstituten | 1.505,2000 | 2.110,8000 | 3.134,7000 | 2.979,3000 | 2.545,4000 | ||||||
Rückstellungen | - | - | - | - | - | ||||||
Verbindlichkeiten | 1.959 | 2.789,3000 | 3.826,8000 | 3.753,2000 | 3.469,1000 | ||||||
Gezeichnetes Kapital | - | 1 | 1,1000 | 1,1000 | 1,1000 | ||||||
Eigenkapital | 344,6000 | 619,5000 | 779,3000 | 928,7000 | 1.424,6000 | ||||||
Minderheitenanteile | 137,6000 | 146,3000 | 167,9000 | 192,8000 | 242,9000 | ||||||
Passiva, gesamt | 2.534,4000 | 3.408,8000 | 4.606,1000 | 4.681,9000 | 4.893,7000 |
Gewinn- und Verlustrechnung
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Umsatzerlöse | 2.273,2000 | 2.374,3000 | 3.115,7000 | 3.707,2000 | 3.971,4000 | ||||||
Abschreibungen (Gesamt) | 94,7000 | 107,7000 | 139,7000 | 172,6000 | 183,8000 | ||||||
Betriebsergebnis | 482,3000 | - | - | - | - | ||||||
Zinsergebnis | -100,4000 | 109,2000 | 142,9000 | 172,1000 | 154,4000 | ||||||
Ergebnis vor Steuern | 384 | 386,9000 | 395,6000 | 482 | 496,4000 | ||||||
Ertragsteuern | 12,7000 | 110,7000 | 141,9000 | 163,9000 | 160,6000 | ||||||
Gewinnanteil Minderheitsgesellschafter | -57,8000 | -59,7000 | -69,7000 | -70,5000 | -79,1000 | ||||||
Konzernjahresüberschuss | 323,6000 | 215,7000 | 181,5000 | 247,6000 | 256,3000 |
Pro Aktie
Cash Flow
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow aus laufender Geschäftstätigkeit | 470,3000 | 444,9000 | 484,8000 | 605,5000 | 657,2000 | ||||||
Cash Flow aus Investitionstätigkeit | -226,2000 | -876,9000 | -1.129,8000 | -245 | -284,5000 | ||||||
Cash Flow aus Finanzierungstätigkeit | -312,4000 | 434,2000 | 639,9000 | -381,6000 | -358,8000 | ||||||
Veränderung der liquiden Mittel | -68,3000 | 2,2000 | -5,1000 | -21,1000 | 13,9000 | ||||||
Anzahl der Mitarbeiter | 23.600 | 29.000 | 34.700 | 35.710 | 29.370 |